Get the app
US › Financial Services

Helius Medical Technologies Inc Class A (HSDT)

US · Financial Services · Asset Management

$2.24-4.68%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$2.5M
Revenue YoY
+5774.4%
Net profit
$-30.3M
EPS
$-0.05
EPS estimate
$-0.02
Net margin
-1,197.8%

EPS came in at -0.05 against a street estimate of -0.02 — a miss of 150.0%.

Key statistics

Market cap
$153.0M
P/E
0.0
Forward P/E
0.0
P/B
1.03
Book value
$2.81
EPS (TTM)
$53.74
52-week high
$15.80
52-week low
$1.19
50-day MA
$2.27
200-day MA
$2.15
Beta
1.12

Analyst view

Analysts rate Helius Medical Technologies Inc Class A a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $3.50.

Shareholding

Insiders
16.20%
Institutions
25.86%

Largest institutional holders

FundStake
Pantera Capital Partners LP8.21%
Kathmere Capital Management, LLC7.57%
Arrington Capital Management, LLC1.08%
BlackRock Inc1.04%
VR Advisory Services Ltd0.96%
LPL Financial Corp0.92%
Vanguard Capital Management, LLC0.92%
Geode Capital Management, LLC0.84%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Helius Medical Technologies Inc Class A — free to start.

Open in the appGoogle PlayApp Store

Other Financial Services companies

Berkshire Hathaway IncBerkshire Hathaway IncJPMorgan Chase & CoVisa Inc. Class AMastercard IncBank of America CorpHSBC Holdings PLC ADRMorgan StanleyRoyal Bank of CanadaGoldman Sachs Group IncWells Fargo & CompanyMitsubishi UFJ Financial Group Inc ADR

Data updated 2026-10-18.